Outstanding results in extraordinary times
March 20, 2020
M.D. Class of 2020 delivers 100 percent match, partners with program, alumni teams to create Alt Match Day.
OHSU, UP students provide child care for frontline health care workers
March 20, 2020
'If we couldn’t be directly involved with caring for patients, we wanted to support the physicians, nurses and medical personnel'
OHSU health leaders ask public to avoid spring break travel in Oregon and beyond
March 19, 2020
Restricting travel can minimize virus transmission from city centers into rural areas with limited health resources.
Nike leaders donate $7 million to support OHSU’s COVID-19 response
March 18, 2020
Gift strengthens statewide care network, supports operational readiness, and builds capacity for diagnostic testing in Oregon.
OHSU moves proactively to sustain its workforce
March 13, 2020
Offers additional sick leave and hardship fund for affected workers.
Bridget OConnell-Long
March 12, 2020
Bridget O'Connell-Long, pediatric resident at OHSU Doernbecher Children's Hospital.(OHSU)
Pediatric resident fears for at-risk, providers who care for them during outbreak
March 12, 2020
Urges collaboration to ensure that efforts are coordinated, safe, evidence-based.
Reflecting, following the lead of women who made history
March 09, 2020
Celebrate the accomplishments of leaders, ourselves, and one another.
First presumptive case of COVID-19 at OHSU
March 08, 2020
Standard precaution protocols have been activated.
BRILLIANCE trial
March 04, 2020
Staff at Oregon Health & Science University's Casey Eye Institute perform the first-ever in vivo CRISPR gene edit procedure for the BRILLIANCE clinical trial. The study uses the gene-editing technology CRISPR to repair mutations in the CEP290 gene that cause a rare form of inherited blindness called Leber congenital amaurosis type 10. The trial is sponsored by Allergan plc. and Editas Medicine. (OHSU/Kristyna Wentz-Graff)